OLVEREMBATINIB

Clinical trials for OLVEREMBATINIB explained in plain language.

Never miss a new study

Get alerted when new OLVEREMBATINIB trials appear

Sign up with your email to follow new studies for OLVEREMBATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug combo tested for Tough-to-Treat leukemia

Disease control Not yet recruiting

This study is testing if a new combination of two drugs, given as an injection and a pill, can help control a specific type of aggressive blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). It will involve about 60 adults, either newly diagnos…

Matched conditions: OLVEREMBATINIB

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

OLVEREMBATINIB

Get alerted when new OLVEREMBATINIB trials appear

New drug combo tested for Tough-to-Treat leukemia